Pathology Holdings
Pathology Holdings is a Torrance, California-based specialty pathology lab founded in 1979 that provides reproductive FDA donor testing, anatomic, molecular, and digital pathology services to fertility clinics and broader clinical referral customers.
- Company typePrivate
- Founded1979
- HeadquartersTorrance, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Pathology Holdings does
Pathology Holdings is a private, for-profit specialty pathology services company headquartered in Torrance, California, founded in 1979. The company delivers expertise in four sub-disciplines: reproductive FDA donor testing, anatomic pathology, molecular pathology, and digital pathology services. Its operating footprint of 251-500 employees and 45+ year history suggest an established mid-sized reference laboratory serving the reproductive medicine and broader clinical pathology markets.
The company's service mix spans both traditional anatomic pathology and the more technology-intensive molecular and digital pathology modalities, indicating a deliberate positioning across legacy and next-generation diagnostic workflows. Reproductive FDA donor testing is a regulated specialty typically serving fertility clinics, sperm banks, egg donor agencies, and related reproductive medicine providers, while anatomic and molecular pathology suggest broader hospital, physician-office, and specialty-clinic referral channels. The inclusion of "digital pathology" points to slide-imaging and digital workflow capabilities that increasingly underpin modern pathology operations, though specific technology platforms, instrument vendors, and proprietary systems are not disclosed in the available data.
The business model appears to be a B2B reference-lab model: specimens are submitted by clinical customers, the lab performs testing under its regulatory authorizations, and revenue is generated per test or per panel. Specific pricing, contract structures, payer mix, and go-to-market channels are not disclosed in the input data. The company has raised approximately $24.65M in disclosed equity capital (in October 2009; investors undisclosed), making it lightly capitalized relative to its multi-decade operating history and suggesting it has historically funded growth through operating cash flow. The corporate name "Pathology Holdings" and four-service portfolio are consistent with a multi-entity or roll-up operating structure, though no subsidiary, M&A, or ownership details are confirmed in the source data.
Pathology Holdings firmographics
Firmographics- Name
- Pathology Holdings
- Website
- https://pathologyinc.com
- Company type
- Private
- Founded year
- 1979
- Headcount range
- 251–500 employees
- Short description
- Pathology Holdings is a Torrance, California-based specialty pathology lab founded in 1979 that provides reproductive FDA donor testing, anatomic, molecular, and digital pathology services to fertility clinics and broader clinical referral customers.
- Ownership category
- akta.pro rank
Pathology Holdings industry classification
Industry- Product category
- Clinical Pathology Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)
- akta.pro secondary industries
- Molecular Pathology & Tissue Biomarkers (IHC/ISH, digital pathology-linked markers) (HLAAAMAI), Anatomic Pathology & Histology/Cytology IVD (Tissue Diagnostics) (HLAHAAAE), Pathology Reporting, Synoptic Templates & Cancer Registry Interfaces (HLACAMAJ)
Keywords
Where Pathology Holdings is headquartered
LocationHeadquarters
- HQ city
- Torrance
- HQ country
- United States
- HQ region
- North America
Markets served
Pathology Holdings business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
Pathology Holdings product offering
Product offeringCore offering
Pathology Holdings is a specialty clinical pathology laboratory that provides reproductive FDA donor testing, anatomic pathology, molecular pathology, and digital pathology services. The firm serves healthcare providers requiring diagnostic and screening support for reproductive medicine, oncology, and general clinical pathology needs.
Differentiator
Problem solved
Functional benefit
Products and services
- Reproductive FDA Donor Testing
- Anatomic Pathology Services
- Molecular Pathology Services
- Digital Pathology Services
Companies that use Pathology Holdings
Customer profileIdeal customer profiles2 records
Pathology Holdings technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Pathology Holdings partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights2 records
Pathology Holdings competitors and assessment
Company assessmentDirect peers
- PathGroup: PathGroup is a physician-led pathology platform offering anatomic, molecular, and digital pathology services to hospitals and clinicians across the U.S., directly comparable to Pathology Holdings' multi-modality pathology offering.
- NeoGenomics: NeoGenomics provides oncology-focused anatomic and molecular pathology services, including tumor profiling and biomarker testing; directly comparable to Pathology Holdings' molecular and anatomic pathology lines.
- ProPath: ProPath is a specialty pathology practice providing anatomic and molecular pathology services with subspecialty expertise, comparable to Pathology Holdings' specialty pathology focus.
- Natera: Natera is a molecular diagnostics company with a strong reproductive health and donor testing franchise; directly comparable to Pathology Holdings' reproductive FDA donor testing line.
- Igenomix: Igenomix specializes in reproductive genetics and donor testing services for fertility clinics, directly comparable to Pathology Holdings' reproductive FDA donor testing offering.
Broad incumbents
- AmeriPath (Quest Diagnostics): AmeriPath, now part of Quest Diagnostics, is a national anatomic pathology provider with overlapping anatomic and subspecialty pathology services to Pathology Holdings.
- ARUP Laboratories: ARUP is a large academic reference laboratory offering anatomic, molecular, and specialty diagnostics comparable in scope to Pathology Holdings' clinical and molecular pathology menu.
- Sonic Healthcare USA: Sonic Healthcare operates a national network of anatomic and clinical pathology laboratories with services spanning molecular and digital pathology, broadly comparable to Pathology Holdings' offerings.
Emerging players
- PathAI: PathAI is an AI-driven digital pathology company partnering with biopharma and labs to apply machine learning to histology; relevant as a technology partner/competitor for Pathology Holdings' digital pathology line.
- Ibex Medical Analytics: Ibex provides AI-based cancer diagnostics for anatomic pathology workflows, a directly comparable technology entrant to Pathology Holdings' digital pathology capabilities.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Pathology Holdings social profiles
Digital presencePathology Holdings financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pathology Holdings leadership team
Management profileNumber of profiles
Profiles1 record
Pathology Holdings funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pathology Holdings M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pathology Holdings
What does Pathology Holdings do?
Pathology Holdings is a specialty clinical pathology laboratory that provides reproductive FDA donor testing, anatomic pathology, molecular pathology, and digital pathology services. The firm serves healthcare providers requiring diagnostic and screening support for reproductive medicine, oncology, and general clinical pathology needs.
When was Pathology Holdings founded?
Pathology Holdings was founded in 1979. It employs 251 to 500 people.
Where is Pathology Holdings based?
Pathology Holdings is headquartered in Torrance, United States, in the North America region.
Who are Pathology Holdings's main competitors?
Direct peers on record are PathGroup, NeoGenomics, ProPath, Natera and Igenomix. Broad incumbents are AmeriPath (Quest Diagnostics), ARUP Laboratories and Sonic Healthcare USA. Emerging players are PathAI and Ibex Medical Analytics.
Does Pathology Holdings have an API?
No public API is recorded for Pathology Holdings.
What industry is Pathology Holdings in?
Pathology Holdings's product category is Clinical Pathology Services. Its primary akta.pro industry code is HLAFAMAA, Anatomic Pathology (Histopathology & Cytopathology), with a secondary code of HLAAAMAI, Molecular Pathology & Tissue Biomarkers (IHC/ISH, digital pathology-linked markers). Its NAICS code is 621511 and its SIC code is 8071.